XML 14 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Consolidated Statements Of Operations    
Revenue
Expenses    
Research and development expenses $ 111,822 $ 61,390
General and administrative expenses 669,070 203,807
Total operating expenses 780,892 265,197
Net loss $ (780,892) $ (265,197)
Earnings per share - basic and diluted    
Loss per common share $ (0.01) $ (0.00)
Weighted average shares outstanding 69,167,505 66,575,122